OAM
RCUS icon

Oxford Asset Management’s Arcus Biosciences RCUS Stock Holding History

Oxford Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,420
Closed -$176K – 724
2025
Q1 		$176K Buy
+22,420
New +$260K 0.08% 373
2019
Q4 		– Sell
-29,320
Closed -$267K – 2023
2019
Q3 		$267K Sell
29,320
-18,171
-38% -$146K 0.01% 1498
2019
Q2 		$378K Buy
47,491
+31,012
+188% +$310K 0.01% 1382
2019
Q1 		$206K Sell
16,479
-16,546
-50% -$180K ﹤0.01% 1504
2018
Q4 		$356K Buy
+33,025
New +$386K 0.01% 1332

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Oxford Asset Management's RCUS Position: Q2 2025 in Review

Oxford Asset Management sold out of Arcus Biosciences (RCUS) in Q2 2025, closing a stake of 22,420 shares — an estimated $176K sold.

Oxford Asset Management first reported a position in RCUS in Q4 2018 and held it in 5 quarters. The position peaked at $378K in Q2 2019. 185 funds tracked by Wall St. Rank hold RCUS as of Q2 2025.

  • Oxford Asset Management reported no remaining Arcus Biosciences position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 22,420 Arcus Biosciences shares in Q2 2025, an estimated $176K.
  • Oxford Asset Management first reported a position in Arcus Biosciences in Q4 2018 and held it in 5 quarters.
  • Oxford Asset Management's Arcus Biosciences position peaked at $378K in Q2 2019.
  • 185 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.